Endogenex

Plymouth, MN · Founded 2017 · Privately Held (backing)

Developer of a medical device system designed to improve metabolic function in individuals with diabetes by resetting metabolic signalling in the small intestine. Endogenex is based in Plymouth, MN and was founded in 2017. It was valued at $218 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $190 million across 3 recorded rounds; the latest was a $69.6 million later-stage round in Jun 2024.

PMV mark · valuation
$218.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$190.4M
Last round
Later Stage VC
Jun 2024
What is Endogenex worth?
$218.0MPrivateMarketView mark · Oct 2026

Valued at $218.0M at its later-stage round, Mar 2026. Nothing has traded since.

Free account
More of Endogenex with a free account
  • ·The complete investor list: 11 names
  • ·Watch Endogenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Endogenex funding history

3 rounds
DateRoundRaisedPost-money
Jun 2024Later Stage VC$69.6M▮
Oct 2023Early Stage VC$18.3M▮
Feb 2023Early Stage VC$9.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Endogenex valuation

Endogenex was valued at $218 million at its later-stage round in Mar 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Endogenex raised?

Endogenex has raised $190 million across 3 recorded rounds since 2023. The largest was a $9.2 million early-stage round in Feb 2023; the most recent was a $69.6 million later-stage round in Jun 2024.

Endogenex has filed 3 Form Ds with the SEC since 2023, most recently in Jun 2024 ($69.6 million sold to 11 investors).

How Endogenex's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Endogenex, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Endogenex

What is Endogenex worth?
Endogenex is valued at $218.0M as of Oct 2026. Valued at $218.0M at its later-stage round, Mar 2026. Nothing has traded since.
How much has Endogenex raised?
Endogenex has raised $190.4M in total funding across 3 recorded rounds.
When did Endogenex last raise?
Endogenex last raised in Jun 2024 (Later Stage VC), raising $69.6M.